Sponsor Pipeline

Wang Jianliu Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
1
Recruiting
1
Disease Areas
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-07-28 NCT07731607 Sintilimab Monotherapy in Patients With Stage I-II MSI-H/dMMR Endometrial Cancer Phase 2 Not Yet Recruiting
Active Trials by Phase
Phase 2
2
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07377734 Intrauterine Injection of Type III Collage in FST of EC/AEH Atypical Endometrial Hyperplasia Recruiting
NCT07731607 Sintilimab Monotherapy in Patients With Stage I-II MSI-H/dMMR Endometrial Cancer MMRd Endometrial Cancer of Stage I~II Not Yet Recruiting
Disease Areas
Endometrial Cancer (2)
Get alerts when Wang Jianliu's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free